Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03279185 · ClinicalTrials.gov registry record
Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite
A clinical trial of HIV/AIDS, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- 334
- Enrollment target
- 9
- Study locations
NCT03279185: Completed study of HIV/AIDS, sponsored by Harvard School of Public Health (HSPH).
NCT03279185 is a study of HIV/AIDS that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 334 participants, below the 33,175-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03279185, a study of HIV/AIDS, has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- 334 participants
- Enrollment target
- 9
- Study locations
Study Summary
This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.
Primary Outcome
Factors of interest for this outcome include virologic suppression, immune impairment, immune activation, changes in ART, cumulative exposure to specific ART, viral resistance, co-infections, and host genetic polymorphisms. Data will be collected through chart abstraction.
Conditions Studied
Study Locations (9)
California
- University of Southern California - Los Angeles
- David Geffen School of Medicine at UCLA - Los Angeles
New York
- New York University School of Medicine - New York
- SUNY Stony Brook - Stony Brook
Georgia
- Emory University School of Medicine - Atlanta
Illinois
- Rush University Cook County Hospital Chicago - Chicago
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Boston Medical Center - Boston
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2025-05-31 |
What the finished NCT03279185 record still lists
NCT03279185 is an observational study that tracks outcomes without assigning an intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap, below the 33,175-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower).
The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 0 interventions.
NCT03279185 lists 9 locations in 7 states (California, New York, Georgia).
Frequently Asked Questions
What is clinical trial NCT03279185 about?
NCT03279185 is a clinical study titled "Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite". This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.
What is the current status of trial NCT03279185?
This trial is currently completed. The enrollment target is 334 participants. The study started on 2017-11-01. Estimated completion is 2025-05-31.
What conditions does trial NCT03279185 study?
This clinical trial studies the following conditions: HIV/AIDS.
Who is sponsoring clinical trial NCT03279185?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03279185 being conducted?
This trial has 9 study locations across California, Georgia, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03279185's enrollment target sits among peer trials
334 18th of 61 higher than 44 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
- NCT05722197 · 334 participants · NA
Assessment of Emotion Regulation Strategies Used When Suicidal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI